scholarly journals Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Diabetes Care ◽  
2007 ◽  
Vol 31 (2) ◽  
pp. 353-360 ◽  
Author(s):  
H. R. Black ◽  
B. Davis ◽  
J. Barzilay ◽  
C. Nwachuku ◽  
C. Baimbridge ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Clinical Outcomes ◽  
Heart Attack ◽  
Initial Treatment ◽  
Lipid Lowering ◽  
Prevent Heart Attack Trial ◽  
The Metabolic Syndrome

scholarly journals Baseline Characteristics of Participants in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Hypertension ◽  
2001 ◽  
Vol 37 (1) ◽  
pp. 19-27 ◽  
Author(s):  
Richard H. Grimm ◽  
Karen L. Margolis ◽  
Vasilios Papademetriou ◽  
William C. Cushman ◽  
Charles E. Ford ◽  
...  
Keyword(s):  
Heart Attack ◽  
Lipid Lowering ◽  
Prevent Heart Attack Trial ◽  
Baseline Characteristics

P99 Selection of clinical sites for the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

1995 ◽  
Vol 16 (3) ◽  
pp. 128S-129S
Author(s):  
Sara Pressel ◽  
Debra Egan ◽  
Charles Ford ◽  
Sandra Walsh ◽  
Nancy Miertschin
Keyword(s):  
Heart Attack ◽  
Lipid Lowering ◽  
Prevent Heart Attack Trial ◽  
Selection Of
Sign in / Sign up

Export Citation Format

Share Document